GlassScriptPhysician profile
Abby Smith Barnes
NPI 1033545918
$1,143.04
in general payments reported to CMS, 2019-2025
17 companies · $21.54 in 2025
The $21.54 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $86.62 · 2023: $898 · 2024: $137 · 2025: $21.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $158.83 | 2023-2025 | Panzyga |
| Astrazeneca Pharmaceuticals LP | $157.73 | 2023 | Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $141.71 | 2022-2023 | Dupixent |
| Grifols USA, LLC | $127.86 | 2023 | Prolastin-C Liquid, Xembify |
| Pfizer INC. | $87.98 | 2023 | |
| Csl Behring | $81.99 | 2023 | Hizentra, Haegarda |
| Takeda Pharmaceuticals U.S.A., INC. | $72.41 | 2023 | Glassia, Takhzyro |
| Amgen INC. | $45.14 | 2022-2023 | Tezspire |
| Genzyme Corporation | $43.93 | 2022-2023 | |
| Glaxosmithkline, LLC. | $41.09 | 2023 | Nucala |
| Hikma Pharmaceuticals USA | $39.03 | 2023 | Ryaltris |
| Kaleo, INC. | $30.27 | 2022-2023 | Auvi-Q |
| Teva Pharmaceuticals USA, INC. | $29.75 | 2022-2023 | Cinqair |
| Blueprint Medicines Corporation | $24.20 | 2023 | Ayvakit |
| Corcept Therapeutics | $22.92 | 2024 | Korlym |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $22.08 | 2023 | Ruconest |
| Biocryst US Sales Co., LLC | $16.12 | 2023 | Orladeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.